| Similar Articles |
|---|
 |
Bio-IT World
February 2007
Robert M. Frederickson |
Scramble for CodeLink Customers GE Healthcare has quietly announced that it will stop production of the popular CodeLink array system in 2007. The news was not a complete surprise to some users of the system who felt the company had been backing away from the platform.   |
The Motley Fool
April 25, 2008
Brian Orelli |
Affymetrix Learns About Inertia Slower sales of its older chips drag down growth. |
The Motley Fool
January 11, 2008
Brian Orelli |
Biochip Packaging: Some Settling May Occur Biochip maker Illumina settles its disputes about patents with Affymetrix. |
The Motley Fool
August 6, 2008
Brian Orelli |
Illumina Grabs Some Cash With biochip maker Illumina hitting 52-week highs, it seems inevitable that the company would do a secondary offering to grab some cash -- about $300 million, as it turns out. |
The Motley Fool
January 28, 2005
Karl Thiel |
Affymetrix Raking in the Chips The life sciences research chip maker is enjoying green pastures in the gene business. The company announced fourth-quarter revenues and profits that handily beat consensus expectations, and then gave an upbeat view of 2005. |
The Motley Fool
July 26, 2007
Brian Orelli |
Affymetrix Advances New products and services should help Affymetrix regain market share. Yesterday, the company even announced a small second-quarter profit. |
PC Magazine
July 13, 2005
John R. Quain |
DNA Printing Press A group of scientists believes it has an inexpensive nanoprinting technique that could lead to the mass production of DNA-based chips that could revolutionize disease detection. |
Chemistry World
November 21, 2013
Phillip Broadwith |
Rapid DNA sequencing cleared for the clinic The approval covers Illumina's MiSeqDx instrument, together with two diagnostic assay kits for cystic fibrosis that run on it, and a kit that allows clinical labs to develop their own diagnostic tests. |
Bio-IT World
February 18, 2004 |
Pathology Goes Molecular New technologies are enabling clinical diagnostic laboratories to pave the way toward more personalized cancer therapies |
Bio-IT World
April 15, 2003
Robert M. Frederickson |
Protein Chemistry Surfaces Protein chips seek to do for protein expression profiling what DNA chips did for RNA expression. |
Technology Research News
December 3, 2003 |
Molecule does two-step Duke University researchers have found a way to make a molecule react only when it has been hit by two photons of ultraviolet light, making the molecule a controllable switch. The molecule could eventually be used in optical storage devices and in biochips. |
Wired
June 2000
Brian Alexander |
Biopoly Money Patents and strong-arm tactics are helping make Affymetrix the Intel of biochips. Along the way, Affy wants to turn DNA into a proprietary system. |
The Motley Fool
October 3, 2007
Rich Smith |
Toshiba Says "Me, Too" No sooner had Japanese TV maker Sony announced it will begin commercial production of an 11-inch organic light-emitting diode television in time for Christmas, out came rival Toshiba with a me-too announcement. |
BusinessWeek
November 29, 2004
Ian Rowley |
The Japan That Can Say: "See You In Court" To protect valuable intellectual property, high-tech Japanese companies are uncharacteristically filing lawsuits. Critics of the legal deluge charge that Japan is just trying to erect protectionist import barriers. |
The Motley Fool
September 3, 2009
Anders Bylund |
Is Japan Gunning for Intel? A consortium of Japanese tech titans have banded together to design powerful but power-sipping microprocessors. Who is their real target? |
The Motley Fool
March 31, 2010
Brian Orelli |
When One Patent Means So Much The loss of patents on genes could have far-reaching consequences for drug companies. |
The Motley Fool
February 6, 2008
Brian Orelli |
Insatiable Illumina Revenue is way up at Illumina, but can the company keep it going looking forward? |
Technology Research News
October 6, 2004 |
Chip spots DNA electrochemically A microelectrochemical method of reading DNA chips could be used in portable detectors. It could be use practically in two to five years, according to the researchers. |
The Motley Fool
October 6, 2006
Rich Smith |
Japan's Nuclear Superpower Toshiba takes control of Westinghouse Electric. As a result, at this point in time it looks like Toshiba has become the dominant force in nuclear reactor construction worldwide. Investors, take note. |
Scientific American
June 2005
JR Minkel |
RNA to the Rescue The spectacular discovery that a species of plant can summon up genes its parents have lost highlights biologists' increasing recognition of RNA as a more versatile and important molecule in its own right. |
Bio-IT World
July 14, 2004
Malorye A. Branca |
The Maven of Microarrays Affymetrix Research Institute's CEO, Stephen Fodor, discusses building a tech business without a blueprint |
The Motley Fool
April 24, 2008
Brian Orelli |
Illumina Ignites This biochip maker is on fire. |
Reason
October 2007
Jeff Taylor |
Get the Picture? Patent intimidation: Once again vague patents are blocking innovation rather than encouraging it. |
Technology Research News
September 24, 2003 |
Glow shows individual DNA Researchers have made a type of artificial DNA of that glows when it combines with a specific sequence of natural DNA. In principle, the method could be used to develop DNA chips that directly sense individual DNA molecules. |
The Motley Fool
November 17, 2006
Jack Uldrich |
Neanderthal DNA Enlightens Investors Investors, the superb performance of 454's gene sequencing equipment on such a difficult and important project bodes well for its future prospects. |
The Motley Fool
September 23, 2004
Rich Smith |
Toshiba to Arm Canon Toshiba wants to play on everyone's team: Hitachi Ltd., Matsushita Electric and now Canon as well. |
Chemistry World
April 19, 2012
Andy Extance |
Polymers perform non-DNA evolution Scientists have found that six polymer alternatives to DNA can pass on genetic information, and have evolved one type to specifically bind target molecules. |
BusinessWeek
November 7, 2005
Catherine Arnst |
How Likely Are You To Get Sick? A new DNA database could gauge your risk for disease. |
BusinessWeek
December 19, 2005
Hall & Burrows |
Why Toshiba Is Clamming Up Forget licensing - Toshiba is keeping innovations out of rivals' hands. |
Bio-IT World
August 13, 2003
Kevin Davies |
Playing by Aussie Rules GTG's Mervyn Jacobson discusses the controversial patenting of non-coding DNA. |
The Motley Fool
February 2, 2010
Brian Orelli |
Shaking Up the Biotech Industry A judge will decide if genes are patentable or not. |
The Motley Fool
September 28, 2007
Brian Orelli |
Side Effects No Match for This Tag Team Seven large drugmakers have come together to try and find genetic variations that cause medications to have serious side effects in some patients, but not in others. |
IEEE Spectrum
March 2011
Lucks & Arkin |
Synthetic Biology's Hunt for the Genetic Transistor How genetic circuits will unlock the true potential of bioengineering |
The Motley Fool
October 27, 2010
Ralph Casale |
Companion Diagnostics in Cancer Drug Development Diagnostic companies partnering with drug developers can make for an attractive investment segment. |
Chemistry World
January 27, 2012
Sarah Houlton |
Illumina fends off Roche hostile bid Roche has made a $5.7 billion hostile bid for the genome sequencing company Illumina, after the San Diego, US-based company rejected its initial approach. |
BusinessWeek
May 26, 2011
Bruce Einhorn |
A Post-Fukushima Rebound for Toshiba Toshiba is making record profits from its chip business. To keep growing, it's moving aggressively into alternative energy technologies. |
